Difference between revisions of "Medulloblastoma"
Jump to navigation
Jump to search
| [unchecked revision] | [unchecked revision] |
(Created page with "test") |
|||
| Line 1: | Line 1: | ||
| − | + | __TOC__ | |
| + | |||
| + | == Contributors == | ||
| + | |||
| + | Write your comments here | ||
| + | |||
| + | == Tumor Type == | ||
| + | |||
| + | Write your comments here <ref>Test Reference: Nowell and Hungerford (1962). Chromosome studies in human leukemia. IV. Myeloproliferative syndrome and other atypical myeloid disorders. ''J Natl Cancer Inst'' 29:911-31 PMID:[http://www.ncbi.nlm.nih.gov/pubmed/?term=13939164 13939164] </ref> | ||
| + | |||
| + | == Tumor Classification == | ||
| + | |||
| + | Write your comments here | ||
| + | |||
| + | == Description == | ||
| + | |||
| + | Write your comments here | ||
| + | |||
| + | == IHC Markers == | ||
| + | |||
| + | Write your comments here | ||
| + | |||
| + | == Genomic Gain/Loss/LOH == | ||
| + | |||
| + | Write your comments here | ||
| + | |||
| + | == Rearrangements == | ||
| + | |||
| + | Write your comments here | ||
| + | |||
| + | == Mutations (SNV/INDEL) == | ||
| + | |||
| + | Write your comments here | ||
| + | |||
| + | === From Cosmic Mutated in >20% === | ||
| + | === Mutated in 10-20% === | ||
| + | === Mutated in 5-10% === | ||
| + | === Mutated in 2-5% === | ||
| + | === mtDNA === | ||
| + | |||
| + | == Epigenomics (methylation) == | ||
| + | |||
| + | Write your comments here | ||
| + | |||
| + | == Main Pathways Involved == | ||
| + | |||
| + | Write your comments here | ||
| + | |||
| + | == Clinical Significance == | ||
| + | |||
| + | Write your comments here | ||
| + | |||
| + | == Diagnosis == | ||
| + | |||
| + | Write your comments here | ||
| + | |||
| + | == Prognosis == | ||
| + | |||
| + | Write your comments here | ||
| + | |||
| + | == Therapeutics == | ||
| + | |||
| + | Write your comments here | ||
| + | |||
| + | == Familial Forms == | ||
| + | |||
| + | Write your comments here | ||
| + | |||
| + | ==References== | ||
| + | {{Reflist}} | ||
Latest revision as of 15:07, 24 February 2016
Contributors
Write your comments here
Tumor Type
Write your comments here [1]
Tumor Classification
Write your comments here
Description
Write your comments here
IHC Markers
Write your comments here
Genomic Gain/Loss/LOH
Write your comments here
Rearrangements
Write your comments here
Mutations (SNV/INDEL)
Write your comments here
From Cosmic Mutated in >20%
Mutated in 10-20%
Mutated in 5-10%
Mutated in 2-5%
mtDNA
Epigenomics (methylation)
Write your comments here
Main Pathways Involved
Write your comments here
Clinical Significance
Write your comments here
Diagnosis
Write your comments here
Prognosis
Write your comments here
Therapeutics
Write your comments here
Familial Forms
Write your comments here